The CRISPR gene editing revolution is happening even faster than we expected. Many thought human trials of therapies using the technique were still years away. But yesterday, a US federal committee gave its nod of approval - meaning the first trial could start later this year. The therapy is designed to treat cancer but the main purpose of this first trial is safety. If it succeeds, it will encourage many other groups to start testing treatments that involve CRISPR.[Continues . . .]
Wow. Designer babies coming up.
Now Mitalipov is believed to have broken new ground both in the number of embryos experimented upon and by demonstrating that it is possible to safely and efficiently correct defective genes that cause inherited diseases.